Scoop

Automating regulatory submissions for life sciences

Y CombinatorFall 2025ActiveB2BArtificial IntelligenceB2BBiotechCompliance

What they do

Problem

Biotech teams spend months manually consolidating reports and preparing documents to complete IND regulatory submissions for drug trials.

Solution

AI agents automate the consolidation and document preparation required for IND submissions to speed up trial initiation.

Who it's for

Biotech and life sciences companies preparing IND submissions for first-in-human clinical trials.

Founders

Vincent Park

Founder/CEO

CEO and Co-founder @ Scoop. Previously at Persona and Dropbox. Working on Scoop to help speed up drug trials, starting with IND filings, to help companies bring life-saving treatments to market faster.

Jay Kwon

Founder/CTO

Co-founder and CTO @ Scoop. Ex-Google Search applied AI (Gemini CoT), supported IND and Phase III clinical trial design for ALS therapy at Corestem, prev at Genentech and CJ Bioscience. MS in Computer Science and Biotechnology from Penn.